Nevada prescription medication agreements, documented from statute through practice
Status: Nevada evidence build reviewed through October 4, 2026. This library separates the statewide statutory agreement mandate, related continuation and monitoring duties, implementing regulations, current Nevada practice agreements, and the formal change path.
Current legal baseline
NRS §639.23914 requires a Prescription Medication Agreement when a practitioner intends to prescribe a Schedule II, III, or IV controlled substance for more than 30 days for treatment of pain. The agreement must be entered no later than 30 days after the initial prescription, kept in the medical record, and updated at least annually or whenever the treatment plan changes.
| Agreement subject | Current Nevada requirement |
|---|---|
| Treatment goals | Required. |
| Drug-monitoring consent | Required when testing is medically necessary. |
| Medication adherence | Patient must take the controlled substance only as prescribed. |
| No sharing | Required. |
| Other controlled substances | Must be disclosed. |
| Alcohol and cannabis/cannabinoids | Use must be disclosed. |
| Side effects / overdose | Relevant treatment and overdose history must be disclosed. |
| Prior states of residence / prescription filling | Must be disclosed. |
| Random pill counts | Agreement must authorize them. |
| Change/discontinuation reasons | Must be included. |
| Additional practitioner requirements | Statute expressly allows them. |
Nevada state-level records
- Nevada Prescription Medication Agreement Requirement
- Nevada 90-Day Continuation and High-Dose Review Record
- Nevada PMP, Risk Assessment, and Informed Consent Record
- Nevada Prescriber Scope and Exemptions Record
- Nevada Group-Practice Agreement Implementation Record
- Nevada AB 474 Legislative Origin Record
- Nevada Contract-for-Care Authority and Rulemaking Record
Current Nevada practice records
- Green Valley Orthopedics — Controlled Substance Packet — currently linked from the practice’s live Henderson patient-information page.
- Calderon Medical Group — Opioid Maintenance Agreement — currently linked from the practice’s live Las Vegas forms page and hosted in its current media library.
- Partida Corona Medical Center — Prescription Medication Agreement — currently embedded in the practice’s live electronic patient-intake form.
Separate 90-day review
When Schedule II-IV controlled-substance treatment for pain continues for 90 consecutive days, Nevada requires a validated risk assessment, investigation supporting an evidence-based diagnosis, and a treatment-plan review. At 90 MME or more for 90 days or longer, specialist referral must be considered and continued higher-dose treatment requires a revised plan documenting increased risk.
PMP and informed consent are separate duties
Nevada generally requires prescription-monitoring review before the initial covered prescription and at least every 90 days thereafter, along with an initial evaluation, risk assessment, individualized treatment plan, and informed consent. These duties may appear again in clinic agreements but do not originate solely from the agreement.
Broad professional scope
The Chapter 639 definition of practitioner includes multiple licensed prescriber categories, including physicians, dentists, podiatrists, authorized advanced practice registered nurses, authorized physician assistants, certain optometrists, and others. The pain-agreement statute therefore reaches beyond physician practice alone.
Major exemptions
The agreement and related pain-prescribing provisions generally do not apply in the same way to pain treatment for cancer, sickle cell disease or variants, hospice care, or palliative care. Those categories retain separate informed-consent requirements.
Group-practice implementation
NAC 639.838 allows a patient to enter the required agreement with a group of practitioners. The prescribing practitioner must still review that agreement immediately before issuing a covered prescription and update it when necessary.
Professional-discipline consequence
Violations of the covered Nevada prescribing statutes and implementing regulations are not misdemeanors under §639.23916, but practitioners are subject to professional discipline.
Clinic additions vary materially
Current Nevada practice agreements show how far individual clinics may go beyond the statutory minimum. Examples include one-pharmacy rules, fixed toxicology schedules, testing fees, scheduled-visit-only refills, lost-medication restrictions, marijuana-card conditions, broad information-sharing clauses, and automatic or near-automatic discharge language. Those are classified as practice terms unless another binding authority independently requires them.
Legislative origin and change path
The agreement mandate originated in Assembly Bill 474, approved June 16, 2017 and operational for these provisions beginning January 1, 2018. Because the core requirement is codified in NRS §639.23914, removing it requires legislative amendment. The State Board of Pharmacy may change implementing regulations within statutory authority, and NRS §233B.100 gives interested persons a formal 30-day petition route for regulatory changes.
Submit a missing Nevada agreement
Submit a Nevada Contract for Care
Primary Nevada authorities
- NRS §639.23914 — Prescription Medication Agreement
- NRS §639.23913 — 90-day continuation review
- NRS §639.23507 — utilization report / PMP review
- NAC 639.838 — group-practice agreement implementation
- NRS §233B.100 — regulatory petition process
Reviewed: October 4, 2026.
Evidence boundary: Nevada’s prescription medication agreement is a statewide statutory requirement in defined circumstances. Practice-added clauses, professional-board standards, implementing regulations, and exempt patient categories remain distinct evidence layers.